SCHEMBL4515746

SCHEMBL4515746

CC(C)(C)OC(=O)Nn1c(=O)c2cc(F)c(N3CCC(C(C)(C)NC(=O)OC(C)(C)C)C3)c(Cl)c2n(C2CC2)c1=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.38
SCN5A Q14524 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CACNA1C Q13936 1/20 0.38
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
F10 P00742 1/20 0.30
TNF P01375 1/20 0.30
LITAF Q99732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515740 1.00 KCNH2 (0.38) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4513702 0.87 F10 (0.39) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4510440 0.87 CYP1A2 (0.36) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4501482 0.87 KCNH2 (0.38) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4506720 0.85 KCNH2 (0.39) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4500395 0.85 KCNH2 (0.37) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4504486 0.85 KCNH2 (0.45) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4504495 0.85 KCNH2 (0.45) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4505948 0.85 KCNH2 (0.45) KCNH2SCN5ACYP1A2CYP3A4CYP2D6
SCHEMBL4500391 0.85 KCNH2 (0.37) KCNH2SCN5ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582627-B2 3-Amino-7-[3-(1-aminoethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione; quinolone antibiotics; bactericides; for antibiotic- resistant bacterial infections, ciprofloxacin- resistant ones; inhibiting wild-type and quinolone- resistant mutants of DNA gryase WARNER-LAMBERT COMPANY (US) 2009-09-01 US disclosed
EP-1255739-B1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2008-06-11 EP disclosed
US-20060287308-A1 3-Aminoquinazolin-2,4-dione antibacterial agents ZOETIS WLC LLC 2006-12-21 US disclosed
US-7094780-B1 3-aminoquinazolin-2,4-dione antibacterial agents WARNER LAMBERT COMPANY LLC (US) 2006-08-22 US disclosed
US-20060183762-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS ZOETIS WLC LLC 2006-08-17 US disclosed
EP-1255739-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-11-13 EP disclosed
WO-2001053273-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2001-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183762-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS ABL1, NQO2, CBR3 KCNH2 8/4885SCN5A 470/4885CYP1A2 689/4885
US-20060287308-A1 3-Aminoquinazolin-2,4-dione antibacterial agents ABL1, NQO2, AAAS KCNH2 8/4885SCN5A 473/4885CYP1A2 673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.